Actively Recruiting

All Genders
ID06554275

CCHS SHARE: A Multi-center Longitudinal Natural History Study

Led by Ann & Robert H Lurie Children's Hospital of Chicago ยท Updated on 2025-07-16

125

Participants Needed

1

Research Sites

13 weeks

Total Duration

On this page

Sponsors

A

Ann & Robert H Lurie Children's Hospital of Chicago

Lead Sponsor

G

Groupe Hospitalier Pitie-Salpetriere

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are conducting a multi-center observational study called CCHS SHARE to collect long-term natural history data on Congenital Central Hypoventilation Syndrome (CCHS). This rare disease affects breathing and autonomic functions, and understanding its progression over time is difficult due to limited data. The study aims to build a shared resource by gathering standardized clinical information and patient-reported experiences from several CCHS referral centers to advance knowledge and support future research and treatments. The study collects data from routine clinical care visits at multiple centers, involving participants of all ages and genders with confirmed CCHS diagnoses. Information gathered includes patient and family health reports, medical records, family history, and other relevant data. These data are stored securely in the CCHS SHARE database, which supports collaboration among researchers, clinicians, and patient advocacy groups. Participants contribute information up to every 14 months, including quality of life, caregiver burden, sleep patterns, autonomic symptoms, and clinical features using standardized common data elements. The study monitors these outcomes longitudinally to better characterize CCHS from a clinical perspective. Participation involves regular follow-ups aligned with standard care, and data collected helps guide future clinical studies. The study is funded by the FDA OOPD and led by Ann & Robert H Lurie Children's Hospital of Chicago.

CONDITIONS

Brief Title

CCHS Secure Health-hub Advancing Research Efforts (CCHS SHARE)

Who Can Participate

All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Participants with a confirmed diagnosis of Congenital Central Hypoventilation Syndrome (CCHS)
  • Confirmation includes alveolar hypoventilation and PHOX2B mutation testing results
  • Participants of all ages and genders are eligible
  • Participants must be clinically followed for CCHS
Not Eligible

You will not qualify if you...

  • Participants without a confirmed diagnosis of CCHS
  • Participants without confirmed PHOX2B mutation testing
  • Participants not followed clinically for CCHS

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Long-term Monitoring

Duration - Up to many years

Participants are observed over many years to collect natural history data on Congenital Central Hypoventilation Syndrome (CCHS), including patient and family self-reports, clinical care information, and family history.

Visits up to every 14 months

Trial Site Locations

Total: 1 location

1

Ann & Robert H Lurie Children's Hospital of Chicago

Chicago, Illinois, United States, 60611

Actively Recruiting

Loading map...

Research Team

C

Casey Rand, MSDS

E

Erin Lonergan, MS

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Similar Trials

International Congenital Central Hypoventilation Syndrome (C...

Congenital Central Hypoventilation Syndrome

Actively Recruiting

1 location

Neurocognitive Outcome as a Metric for Evaluating Therapeuti...

Congenital Central Hypoventilation Syndrome

Actively Recruiting

4 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here